Skip to content
Open access

Hepatoprotective Effects of Aqueous Extract of Watermelon (Citrullus lanatus) Seed on Diabetic Wistar Rats

Oct 2026 · European Journal of Medical and Health Research · 0 citations · 37 references

Abstract

Background: Diabetes mellitus is characterised by hypoinsulinemia or insulin insensitivity, poses a significant global health burden. Watermelon (Citrullus lanatus), contain phytochemicals with therapeutic potential. This study investigated the hepatoprotective effects of aqueous watermelon seed extract against induced diabetes in Wistar rats. Methods: Forty adult male Wistar rats were randomly assigned to five groups (n=8): normal control, watermelon seed extract only, diabetic + watermelon seed extract (400 mg/kg), diabetic + metformin (300 mg/kg), and diabetic control. Diabetes was induced by a single intraperitoneal injection of streptozotocin (75 mg/kg). Administration of extract began 72 hours post-induction and continued for four weeks. Biochemical assays, oxidative stress markers, liver enzymes, and histopathological examinations using H&E, Masson Trichrome, PAS, and Congo red stains were performed. Results: Watermelon seed extract+diabetes significantly improved body weight and relative liver weight compared to diabetic control group (p<0.05). Blood glucose levels normalized by week three in the watermelon + diabetes group. Glucose-6- phosphate dehydrogenase activity was preserved, while elevated lactate dehydrogenase activity in diabetic controls was significantly reduced. Oxidative stress markers (glutathione, superoxide dismutase, catalase) were restored toward normal levels. Liver enzymes (AST and ALT) were markedly maintained to normal in watermelon extract + diabetes group, histological evaluation revealed preserved hepatic architecture with reduced necrosis, fibrosis, and minimal amyloid deposition. Conclusion: Aqueous watermelon seed extract demonstrates significant hepatoprotective effects against streptozotocin-induced liver damage, likely mediated through antioxidant defense enhancement and glycemic control. These findings support its potential as a complementary therapeutic agent in diabetes management.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.